---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-016378"
form_type: "8-K"
ticker: "BFRG"
cik: "0001829247"
company_name: "BullFrog AI Holdings, Inc."
filed_at: "2026-04-13T23:59:59+00:00"
generated_at: "2026-05-15T06:36:18.287818+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BullFrog AI secures first commercial agreement with top 5 pharma; runway into late 2027

## Summary
- First commercial feasibility agreement with a top 5 global pharma for bfLEAP platform in MDD (market >$8B).
- Financing in late March 2026 provides runway into late 2027; stockholders' equity >$2.5M meets Nasdaq standard.
- Launched bfARENAS platform in March 2026, completing end-to-end AI platform for pharma R&D.
- Ongoing Lieber Institute collaboration grants access to >2,800 human brain samples for neuropsychiatric targets.

## SEC filing metadata
- accession: 0001493152-26-016378
- form_type: 8-K
- ticker: BFRG
- cik: 0001829247
- company_name: BullFrog AI Holdings, Inc.
- filed_at: 2026-04-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829247/000149315226016378/0001493152-26-016378-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829247/000149315226016378/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-016378
- JSON: https://secwatch.observer/filing/0001493152-26-016378.json
- Plain text: https://secwatch.observer/filing/0001493152-26-016378.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.